TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -3 | 0 | 0 | 0 | 0 | 0 | -3 |
| P | %wins | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/23 10:52 | 2/9/23 | LEXX | Lexaria Bioscience Corp. | NV | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | D | P.d | 4 | 2.84 | 0 | 2 | New | 2 | D | |||||||||||||||
5/22/19 16:12 | 5/20/19 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | P | S.m | -19 | 1.95 | 0 | -10 | -10 | 89 | D | ||||||||||||||
9/13/18 20:00 | 9/11/18 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | P | P.m | 161 | 4.78 | 0 | 34 | 74 | 79 | D | ||||||||||||||
9/7/18 20:00 | 9/5/18 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | P | P | 3 | 3.97 | 0 | 1 | 2 | 45 | I | ||||||||||||||
5/11/17 20:33 | 5/10/17 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | Chief De | P | 111 | 9.99 | 0 | 11 | 83 | 25 | D | -94 | -92 | -34 | -32 | -27 | -5 | 0 | 3 | -3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |